1.
Ann Ophthalmol (Skokie)
; 41(3-4): 174-8, 2009.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20214051
RESUMO
We compared the efficacy and safety of a new fixed combination of timolol 0.5%/odorzolamide 20%/brimonidine 0.2% in ophthalmic solution versus a fixed combination of timolol 0.5%/dorzolamide 2% in patients with open-angle glaucoma or ocular hypertension. The fixed triple combination was significantly more efficient in mean intraocular pressure reduction from baseline throughout the six-month follow-up.